HK$21.18
0.00%
Hong Kong, Sep 18, 09:30 am HKT.
ISIN
CNE100004QP1
Symbol
2252

Shanghai Microport Medbot-h Stock price

HK$21.18
-2.58 10.86% 1M
-1.42 6.28% 6M
-3.12 12.84% YTD
-6.60 23.76% 1Y
+3.84 22.15% 3Y
-24.62 53.76% 5Y
-24.62 53.76% 10Y
-24.62 53.76% 20Y
Hong Kong, Closing price Mon, Sep 21 2026
+0.00 0.00%
ISIN
CNE100004QP1
Symbol
2252

Is Shanghai Microport Medbot-h a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,133 stocks worldwide.

Key metrics

Basic
Market capitalization
HK$22.0b
Enterprise Value
HK$21.7b
Net debt
positive
Cash
HK$745.5m
Shares outstanding
1.0b
Valuation (TTM | estimate)
P/E
negative
P/S
34.0 | 15.7
EV/Sales
33.6 | 15.5
EV/FCF
negative
P/B
45.7
Financial Health
Equity Ratio
30.8%
Return on Equity
-60.8%
ROCE
-18.6%
ROIC
-265.0%
Debt/Equity
1.0
Financials (TTM | estimate)
Revenue
HK$645.3m | HK$1.4b
EBITDA
-
EBIT
HK$-192.4m
Net Income
HK$-292.4m
Free Cash Flow
HK$-29.7m
Growth (TTM | estimate)
Revenue
114.2% | 116.7%
EBITDA
-
EBIT
65.4%
Net Income
61.1%
Free Cash Flow
92.6%
Margin
Gross
48.4%
EBITDA
-
EBIT
-29.8%
Net
-45.3%
Free Cash Flow
-4.6%
More
EPS
HK$-0.3
FCF per Share
HK$0.0
Short interest
-
Employees
464
Rev per Employee
HK$1.4m

Shanghai Microport Medbot-h Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Shanghai Microport Medbot-h forecast:

13x Buy
87%
2x Hold
13%

Analyst Opinions

15 Analysts have issued a Shanghai Microport Medbot-h forecast:

Buy
87%
Hold
13%

Financial data from Shanghai Microport Medbot-h

Dec '25
+/-
%
645 645
114% 114%
100%
- Direct Costs 333 333
66% 66%
52%
312 312
209% 209%
48%
- Selling and Administrative Expenses 292 292
5% 5%
45%
- Research and Development Expense 253 253
30% 30%
39%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -192 -192
65% 65%
-30%
Net Profit -292 -292
61% 61%
-45%

In millions HKD.

Don't miss a Thing! We will send you all news about Shanghai Microport Medbot-h directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, manufacturing, and sale of surgical robots. The company is headquartered in Shanghai, Shanghai and currently employs 464 full-time employees. The company went IPO on 2021-11-02. The firm's business covers the fields of laparoscopic, orthopedic, panvascular, natural orifice and percutaneous surgical procedures. The firm's products include Toumai LaparoscopicSurgical Robot, Toumai Single-port Laparoscopic Surgical Robot, DFVision Three Dimensions (3D) Electronic Laparoscope, SkyWalker Orthopedic Surgical Robot, Trans-bronchial Surgical Robot, R-ONE Vascular Interventional Robot, and iSR’obot Mona Lisa RoboticTransperineal Prostate Biopsy System. The firm conducts its businesses in domestic and overseas markets.

Head office China
Employees 464
Website www.medbotsurgical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today